Document Mentions (3 shared documents)

EFTA00135712

2 mentions1 same-page

Page ?Same page

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

Policy and Regulatory Manager Alexandra Wyatt; 10:00 AM • House Agriculture subcommittee hybrid hearing on conservation programs - Conservation and Forestry Subcommittee hybrid hearing on 'Challenges and Successes of Conservation Programs in 2020' * Held via Cisco Webex and in Rm 1300, Longworth House Office Building

EFTA00148896

2 mentions1 same-page

Page ?Same page

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

licy and Regulatory Manager Alexandra Wyatt; 10:00 AM • House Agriculture subcommittee hybrid hearing on conservation programs - Conservation and Forestry Subcommittee hybrid hearing on 'Challenges and Successes of Conservation Programs in 2020' * Held via Cisco Webex and in Rm 1300, Longworth House Office Buildin

EFTA01658495

2 mentions1 same-page

Page ?Same page

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

Mutual Connections (893)

Entities connected to both Amgen and Forestry Subcommittee

Jeffrey Epstein